Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans

Diabetes, Obesity and Metabolism

Volumn 15, Issue 5, 2013, Pages 474-477

  Wu, T ^a   Bound, M J ^a   Standfield, S D ^a   Gedulin, B ^b   Jones, K L ^a   Horowitz, M ^a   Rayner, C K ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Satiogen Pharmaceuticals   (United States)

Author keywords

Bile salt; Glucagon like peptide 1; Peptide YY

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; PEPTIDE YY; TAUROCHOLIC ACID;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); DEFECATION HABIT; DRUG TOLERABILITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PROTEIN SECRETION; RECTAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, RECTAL; ADULT; APPETITE REGULATION; BLOOD GLUCOSE; BODY MASS INDEX; CHOLAGOGUES AND CHOLERETICS; DIABETES MELLITUS, TYPE 2; ENEMA; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; OBESITY; PEPTIDE YY; TAUROCHOLIC ACID; TREATMENT OUTCOME;

EID: 84876326720     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12043     Document Type: Article

References (15)

1. Eissele R, Goke R, Willemer S et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 1992; 22: 283-291.
2. Nauck MA, Heimesaat MM, Behle K et al. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 2002; 87: 1239-1246.
3. Edholm T, Degerblad M, Gryback P et al. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterol Motil 2010; 22: 1191-1200.
4. Witte AB, Gryback P, Holst JJ et al. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regul Peptides 2009; 158(1-3): 57-62.
5. Kawamata Y, Fujii R, Hosoya M et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278: 9435-9440.
6. Thomas C, Gioiello A, Noriega L et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10: 167-177.
7. Sato H, Macchiarulo A, Thomas C et al. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem 2008; 51: 1831-1841.
8. Izukura M, Hashimoto T, Gomez G, Uchida T, Greeley GH Jr, Thompson JC. Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs. Pancreas 1991; 6: 427-432.
9. Adrian TE, Gariballa S, Parekh KA et al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia 2012; 55: 2343-2347.
10. Parker BA, Sturm K, MacIntosh CG, Feinle C, Horowitz M, Chapman IM. Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr 2004; 58: 212-218.
11. Adrian TE, Ballantyne GH, Longo WE et al. Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut 1993; 34: 1219-1224.
12. El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG, Hausken T. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci 2012; 57: 873-878.
13. Sadik R, Abrahamsson H, Ung KA, Stotzer PO. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004; 99: 711-718.
14. Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol Motil 2011; 23: 995-999; e458.
15. Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 1978; 62: 152-161.